HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)
IceCure Medical (NASDAQ:ICCM – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $3.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 305.41% from the stock’s […]
More Stories
Bonterra Resources Inc. (OTCMKTS:BONXF) Short Interest Down 50.8% in September
Bonterra Resources Inc. (OTCMKTS:BONXF – Get Free Report) saw a large decline in short interest during the month of September....
Short Interest in Bridges Capital Tactical ETF (NASDAQ:BDGS) Decreases By 50.0%
Bridges Capital Tactical ETF (NASDAQ:BDGS – Get Free Report) was the target of a significant decline in short interest in...
Premium Income 40 Barrier ETF (BATS:JULQ) Plans Dividend of $0.31
Premium Income 40 Barrier ETF (BATS:JULQ – Get Free Report) declared a dividend on Friday, September 27th, NASDAQ reports. Shareholders...
Vest 2 Year Interest Rate Hedge ETF (HYKE) To Go Ex-Dividend on September 30th
Vest 2 Year Interest Rate Hedge ETF (NYSEARCA:HYKE – Get Free Report) announced a dividend on Friday, September 27th, NASDAQ...
Cosan S.A. (NYSE:CSAN) Short Interest Update
Cosan S.A. (NYSE:CSAN – Get Free Report) saw a significant growth in short interest in September. As of September 15th,...
Quisitive Technology Solutions, Inc. (OTCMKTS:QUISF) Short Interest Update
Quisitive Technology Solutions, Inc. (OTCMKTS:QUISF – Get Free Report) saw a large decrease in short interest in September. As of...